Ed Talman, Synvolux

Title: Use of HER2/neu targeted Trastuzumab for intracellular and functional delivery of macromolecules
Session: Tuesday 6 October, 12:00

Abstract

 to be announced

 

 

 

Bio

 to be announced

 

Powered by Invitado Visitor Management